Kicking Gout in the Acid

Gout Education Society

Learn more about gout causes, symptoms, and treatment with Gout Education Society Chairman, Larry Edwards, MD, MACR, MACP, alongside other gout experts from across the world.

Episodes

  1. May 4

    Gout Rx: Past, Present, and Future

    Welcome to the second season finale Kicking Gout in the Acid. This season dove into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. The season finale of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Dr. Brian Mandell, rheumatologist from the Cleveland Clinic, and member of the Gout Education Society’s Board of Directors. In this episode, Dr. Edwards and Dr. Mandell will look back at the history of gout treatment, discuss the current state of affairs for medications in development, and look towards the future of disease management.  Key Takeaways: Early treatments focused on symptom relief rather than the underlying disease, delaying recognition of gout as a condition driven by urate deposition that requires targeted, long‑term management. Medications like probenecid and later allopurinol reframed gout as a chronic condition that can be controlled by consistently lowering and maintaining serum urate to a defined target. This strategy opened the door to new options like febuxostat, uricosurics, and uricase-based therapies that allow for more individualized care. The future of gout treatment is bright with options as many are in the clinical pipeline. To Dr. Edwards and Dr. Mandell, an option that not only lowers urate more effectively but also directly targets inflammation pathways could be an interesting area of future research. Gout is treatable and curable when managed correctly. Successful outcomes depend on a team-based approach involving informed patients, appropriate medication use, adherence to treat‑to‑target principles, and consistent follow‑up. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi.

    25 min
  2. Mar 31

    Heart Health and Gout: Connecting the Dots

    Welcome to season two of Kicking Gout in the Acid. This season will dive into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. This episode of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Dr. Ken Saag, rheumatologist, professor, and director in UAB Medicine’s Division of Clinical Immunology and Rheumatology, member of the Gout Education Society’s Board of Directors. The two dive into the link between gout and cardiovascular disease, why flares may increase risk for CV events, and clinical recommendations that medical professionals should consider when someone faces both conditions. Key Takeaways: The link between gout and cardiovascular disease remains complex and often misunderstood. While biological plausibility exists, human data are mixed, creating uncertainty about how strongly uric acid contributes to long‑term heart outcomes. Gout flares themselves may carry cardiovascular risk. Acute flares are highly inflammatory, and emerging evidence suggests they may directly increase the likelihood of cardiovascular events which underscores the need for proactive flare prevention. Those with both gout and heart disease benefit from aggressive management based on the treat-to-target approach. Lowering serum urate, preventing flares, and maintaining overall cardiovascular stability remain key goals for improving outcomes for those facing both conditions. Lifestyle changes can be helpful in those with gout, but medication is essential to treat a majority of cases. Although weight loss and dietary changes provide modest improvements, they rarely reduce uric acid enough on their own. Sustainable management still depends on appropriately titrated urate‑lowering therapy. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi.

    28 min
  3. Feb 23

    The Challenge of Coordinated Gout Treatment

    Welcome to season two of Kicking Gout in the Acid. This season will dive into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. This episode of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Dr. Tuhina Neogi, Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine (BUSM), Chief of Rheumatology at Boston Medical Center, and member of the Gout Education Society’s Board of Directors. The two explore the common areas where gout patients are seen, common pitfalls that occur throughout the process of multidisciplinary management, and the importance of promoting the ACR gout guidelines among professionals. Key Takeaways: Gout is still not viewed as an important rheumatic disease by many providers, leading to under-treatment and missed opportunities for proper management. Under-treated gout, or treatment only focused on symptoms, can lead to uncontrolled hyperuricemia, worsening tophi, and patients losing trust in their physicians. There is growing involvement in specialists treating gout, however, inconsistent knowledge on managing the disease can lead to unnecessary medication holds, recurrent flares, and patient confusion. Many myths still hold the attention of those with the disease and medical professionals alike. Notably, the disease shouldn’t be seen as episodic, rather it should be seen as chronic, requiring lifelong therapy that aligns with the treat-to-target approach. Educated patients are advocates for themselves. This can be particularly helpful when their care team has differing opinions. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi. Podcast Transcript Ian PonitzHello, and welcome to Kicking Gout In The Acid, a podcast from the Gout Education Society. My name is Ian Ponitz, and I'm your host for this series. Kicking Gout In The Acid features conversations between Dr. Larry Edwards, chairman and CEO of the Gout Education Society, and experts on the disease.  Each episode will dive into important topics that you, the listener, should know about gout. The goal? To feel empowered to get gout under control.  In this episode, Dr. Edwards is joined by Dr. Tuhina Neogi, professor of medicine at Boston University's Chobanian & Avedisian School of Medicine, also known as BUSM. She is the endowed Allen S. Cohen Professor of Rheumatology and professor of epidemiology at BU School of Public Health, and chief of rheumatology at Boston Medical Center. Dr. Neogi is also a member of the Gout Education Society's board of directors.  Today, Dr. Neogi and Dr. Edwards will discuss the gamut of medical care that gout patients may encounter throughout their journey, issues that can be caused when seeing several disciplines of medicine, and the importance of getting medical professionals on the same page when it comes to managing the disease.  Dr. Edwards, take it from here.  Dr. Larry EdwardsThanks, Ian. I'm delighted to have Dr. Tuhina Neogi on today's Gout Education Society's podcast. Dr. Neogi is an internationally recognized expert on many aspects of rheumatology, but especially in the management of gout. Tuhina, can you give our listening audience a bit of your background and how you got interested in gout?  Dr. Tuhina NeogiSure, happy to. Thank you for having me on this podcast.  I'm originally Canadian. I'm from Toronto, and I did all of my medical training in Toronto. When I was a fellow, I didn't have too much interest in gout, but Dr. Adel Pham was one of my mentors. He was well known for the allopurinol desensitization protocol, so we got a lot of gout teaching.  When I completed my fellowship, in order to have a position on the University of Toronto faculty, I needed to get a master's or PhD, for which I moved to Boston to do that research training. And during that research training, I got a PhD, and as part of my PhD, I had to quickly find a set of thesis dissertation topics, and one of my colleagues, Dr. Yuq Ching Zhang, at the time, was just starting an Internet-based gout study in which we were going to study triggers for gout flares. And it was a very cool study design where each person acts as his or her own control over time, and we studied a whole host of dietary and lifestyle factors as potential triggers for gout flares, and that got me hooked.  So I like to say that, you know, gout is kind of my hobby topic for my research career, because it was kind of a passion project that I've been fortunate to continue working in.  Dr. Larry EdwardsYeah. Well, it's more than a little hobby, because you are certainly an internationally recognized expert in the field, and we're delighted to have you on today.  What we're gonna be discussing is the wide range of physicians and medical professionals who may encounter patients with gout, and how they contribute to the overall care. And we're also gonna be discussing how being seen by multiple different care providers may impact the overall level of treatment, and how interaction should take place, and unfortunately, how most of the time they don't.  So let's start off just by discussing at the various stages of gout who might first come in contact with somebody who's suffering from gout.  Dr. Tuhina NeogiYeah. So the vast majority of patients with gout, as you know, are managed in primary care, so that really is the first stop on the patient's journey. And for some patients, they may not be advised adequately about gout and its consequences, and as a result, may not be started on urate-lowering therapy even if they meet the clinical indications for starting such therapy.  Some patients may be simply placed on anti-inflammatory suppressive therapy with colchicine just to try to prevent flares or have flares treated as they occur. Unfortunately, that leads to unabated hyperuricemia to continue on for years. And I'm sure you have a much vaster experience than I do of all the patients that come to us after years of such an approach, where they now have bad tophaceous gout with lots of flares or chronic arthritis where the inflammation is there persistently, and are frankly quite upset that their primary care physician allowed this to occur over the years.  It unfortunately detracts from the trust they have with their primary care physician that if this is what happened with their gout, what else might be happening with their other medical conditions. So that's the majority of it. I would say that I see some patients coming from nephrology or cardiology, where they happen to either check the urate for some reason, or it's one of the visits where the patient happens to mention that they need to take NSAIDs because of their gout.  Dr. Larry EdwardsYeah, might be on any number of drugs that influence the frequency of gout flares or the ability to take certain compounds.  In addition to those, Tuhina, a number of patients get their care from urgent care settings or emergency departments. I think I see a lot of patients. On a typical week, I might get called down to the emergency department maybe a half a dozen times to discuss the differential diagnosis of a single inflamed joint. But the thing with urgent care and with emergency departments is that they're really interested in getting the patient out of their acute facility, and so people can go on for years just following up in that setting and not getting the message.  Really, what we're pushing, and what you've certainly an expert in, is the treat-to-target approach of taking care of gout, and what you're describing from a lot of the primary care physicians is really to avoid symptoms with the use of colchicine or nonsteroidals. Dr. Tuhina NeogiYou made a good point about primary care often using colchicine or NSAIDs on that kind of as-needed basis.  To me, a perspective we could adopt would be for us as rheumatologists to say to cardiologists, "Oh, your patient has cardiovascular disease. There's no need to treat the underlying biology of the cardiovascular disease. There's no need to treat the hypercholesterolemia, the hypertension, the diabetes, obesity, smoking, et cetera. Why don't you just give them sublingual nitroglycerin, and they can just use it as needed or even, you know, use it chronically to prevent the chest pain? But all you need to do is treat the chest pain, not all of the underlying biology."  Or an even perhaps more ridiculous way to drive home the point is telling a pulmonologist for a patient with tuberculosis, "No need to use anti-tuberculous therapy. Just use an antipyretic and an antitussive. Just, you know, treat the fever, treat the cough. No need to treat the underlying bacteria." And I think that's the kind of blunt messaging we might need to explain why treating the underlying hyperuricemia is the cornerstone and foundation of managing gout, not just the clinically evident symptomatic flares.  Dr. Larry EdwardsYeah. Those are excellent points.  Dr. Tuhina NeogiI think over the last few decades, I've queried my primary care friends just about the problems of getting good care for gout. A lot of them will bring up the issues that, you know, they are primary care, so they're not just looking after the occasional gout symptoms that occur, but they have, you know, the same patients might have heart disease, diabetes, various other met

    26 min
  4. Jan 30

    Gout and Genetics: What Your Background Might Mean

    Welcome to season two of Kicking Gout in the Acid. This season will dive into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. This episode of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Dr. Robert Keenan, Rheumatologist, Chief Medical Officer at Arthrosi Therapeutics, and member of the International Advisory Council for the Gout Education Society. The two explore the broad reach of gout across different demographics, discuss how gout presents differently, and considerations healthcare professionals should be aware of during treatment. Key Takeaways: Gout doesn’t discriminate by age, gender, background, or diet. Doctors should be aware that the signs of gout aren’t always as straightforward. Misdiagnosis is common, so it’s important to take a step back and recognize the subtle symptoms. Genetics play a meaningful, but complex, role. Family history is a significant risk factor, however, research points to polygenic and epigenetic factors than one single genetic mutation. Demographics matter, but not in the way most people think. While men typically develop gout in their 40s-50s, the prevalence is nearly equal in women post-menopause. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi. Podcast Transcript Ian PonitzHello, and welcome to Kicking Gout In The Acid, a podcast from the Gout Education Society. My name is Ian Ponitz, and I'm your host for this series. Kicking Gout In The Acid features conversations between Dr. Larry Edwards, chairman and CEO of the Gout Education Society, and experts on the disease. Each episode will dive into important topics that you, the listener, should know about gout. The goal? To feel empowered to get gout under control. In this episode, Dr. Edwards is joined by Dr. Robert Keenan, Chief Medical Officer at Arthrosi Therapeutics, and member of the Gout Education Society's International Advisory Council. Today, Dr. Keenan and Dr. Edwards will discuss how gout affects different populations, the role of genetics and gender on gout, and how medical professionals can better serve diverse communities. Dr. Edwards, take it from here. Dr. Larry EdwardsThanks, Ian. I'm happy to be joined today by Dr. Robert Keenan, internationally recognized expert in the field of gout. He's also the Chief Medical Officer of Arthrosi Therapeutics, and I'm delighted to have us join in our conversation. Can you start off, Rob, by telling a little bit about what your interest in gout has been over the years and what kind of studies and research you've done? Dr. Robert KeenanYeah. Thanks for having me. I appreciate the opportunity to talk about my favorite medical topic or my favorite topic, probably in general, much to my wife's dismay, of gout. Yeah, so I got interested in gout back in medical school, quite honestly, and then my interest further developed in residency, then subsequently in fellowship. I had the opportunity at NYU to start a gout registry with the VA there, and that kind of really kicked off my clinical research interest. From there, I just continued it on as I transitioned to Duke University, and I started a gout clinic and kept up with the clinical research there as a principal investigator for a number of drug studies, as well as principal investigator for some epidemiological studies that were externally funded. So that's kind of how I kept the love of gout and the love of treatment of gout and taking care of this patient population over the last twenty-plus years now. Dr. Larry EdwardsYeah, it's an incredibly interesting disease with a crazy history to it. It certainly is a fun thing to study, and the nice thing is that it's essentially a curable disease if patients listen to the recommendations. We have good medications. We're getting better medications coming down the pipeline, so I think that there's a lot of hope for the future. Let's go ahead, Rob, and start off the discussion today, talking really about the demographics of gout, who gets gout. It's said that there's about 9 to 12 million adults in the United States that have gout, coming to about 4% of the population of adults. What else can you tell us about the demographics of this disease? Dr. Robert KeenanYeah. So I like to tell patients that gout doesn't discriminate. I mean, there's a lot of misnomer about. Oh, it's the over-indulgent rich person who eats too much, you know, meat and drinks too much alcohol, that gets you gout. But really, I mean, just pretty much gout can affect any ethnicity, any race across the spectrum. Of course, men are more likely to get gout earlier on, so you think about the typical gout patient as a man in his fifties, you know, late forties, early fifties when they first initially present with their first flare. But eventually, women do catch up with men post-menopausal. So once they reach menopause, the incidence and prevalence of gout in women starts to catch up with that of men. So by the time they're seventy-five, eighty, it's pretty much almost equal to that of men. Again, it can affect anybody. Now, typically, as far as who gets gout the most, so to speak, there was a recent study that was put out by Yokosi a couple of years ago. I guess it was twenty twenty-three years ago that showed that over the last couple of decades, the Asian population in the US, actually, their prevalence doubled from about 3.3% to about 6.6%. That was a higher increase and a higher rate of increase in prevalence compared to every other ethnic group, including whites and blacks and Hispanics. So I thought that was interesting. If you look at the black population in general, their prevalence of gout is also higher than that of whites. And you can think, “Well, maybe this is something genetic,” and it's probably not genetics, especially when people develop gout in their fifties and sixties. You know, you’ve got to think about a genetic component when they're developing gout in their late teens or twenties, for example. But it's not so much genes as it is just potentially lifestyle, other comorbid illnesses like chronic kidney disease or metabolic syndrome. If you look at that Yokosi study of the Asian population being doubled, you know, it wasn't double. It was actually lower than whites about thirty years ago. So, as with blacks, it could be just a lack of access to care. It could be not being started on urate-lowering therapy when they should. So that kind of pretty much dictates, and if they develop gout and have not started on anything to bring their uric acid down, then they're more likely to have gout longer, more flares, and more severe gout down the road. Dr. Larry EdwardsThere's been a lot of work on the genetics of it, and we can talk about that in a short while. I think other components you've mentioned are the gender, of course, with men predominant early on in the forties, fifties, and sixties, and women becoming much more susceptible to gout as they get into their seventies and eighties. The frequency of gout in that older population, seventy-five, eighty, is actually very high, 20%, 25% percent of the population of adults. Can you talk a little bit about age? You mentioned earlier on, Rob, that the image that most people have of gout is some portly old white guy sitting around drinking some alcoholic beverage or eating a large meal. We know that that's not the primary source of problems. Can you talk about the type of people that you see that would really say that that's not the problem, as far as women, as far as athletes getting it, people that don't drink, people that don't eat meat? All of those are in the spectrum. Dr. Robert KeenanYeah, exactly. So that's where potentially some of those genes kind of come into play in that patient population, especially whether it's women, and just post-menopausal, and especially if they have a strong family history, their father had gout, their grandfather had gout, their brothers have gout, there's a good chance they'll develop gout. A lot of times, in women, they'll present different than men. They won't necessarily present with a big, hot, painful red big toe. They'll present with it in their hands, for example, and it might not even flare like a typical gout flare. It might be a little more subtle. And I think that's important for women to recognize because, you know, I've had patients, women patients who came to me for joint pain in their hands, and, you know, they obviously had some osteoarthritis in their hands, and they came to me saying their pain's just getting worse, and they're having episodes where it's just worse some days than others. Sure enough, I say, "Well, this looks like it could be potentially gout." And, you know, one patient I can think of off the top of my head said, "I don't have gout. My husband has gout, but I don't have gout. There's no way I have gout. He eats too much," et cetera, et cetera. I said, "Well, I think you may have gout. Let's take some X-rays and see what we see, and then check uric acid and see what we see." And sure enough, she had gout on top of her osteoarthritis in her hands. So that patient population certainly is not gonna be necessarily typical in many ways, not only, you know, necessarily what they're eating or not eating,.

    18 min
  5. 12/10/2025

    The Two-Way Street: Gout’s Impact on Renal Function – and Vice Versa

    Welcome to season two of Kicking Gout in the Acid. This season will dive into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. This episode of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Dr. Richard Johnson, board-certified nephrologist and member of the Board of Directors for the Gout Education Society. The two explore the connection between gout and kidney health through topics like uric acid regulation through the kidneys, treatment options, and considerations for medical professionals in charge of care should keep in mind. Key Takeaways: The kidneys play a central role in uric acid regulation. About two-thirds of uric acid is excreted by the kidneys, and one-third by the gut. When kidney function declines, uric acid retention occurs, increasing gout risk. Kidney disease and gout are closely linked to one another. Chronic kidney disease (CKD) is a major cause of gout because impaired kidney function leads to uric acid buildup. Conversely, high uric acid may contribute to CKD progression, creating a vicious cycle. In those with kidney disease, treatment can look a bit different. Notably, NSAIDs may not be an option due to their harmful impact on the kidneys. For those with kidney disease looking for pain relief from a gout flare, options like steroids should be considered. Also, historical dosing restrictions for allopurinol in CKD have led to undertreatment, but recent evidence supports gradual titration to higher doses when monitored. For medical professionals, it’s important to screen those with gout for kidney disease and vice versa. Medications known to raise uric acid should also be reviewed, namely, diuretics. Comorbidities should always be considered when treating gout. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi. Podcast Transcript Ian PonitzHello, and welcome to Kicking Gout In The Acid, a podcast from the Gout Education Society. My name is Ian Ponitz, and I'm your host for this series. Kicking Gout In The Acid features conversations between Dr. Larry Edwards, chairman and CEO of the Gout Education Society, and experts on the disease. Each episode will dive into important topics that you, the listener, should know about gout. The goal? To feel empowered to get gout under control. In this episode, Dr. Edwards is joined by Dr. Richard Johnson, board-certified nephrologist, professor emeritus at the University of Colorado Anschutz Medical Campus, and board member of the Gout Education Society. Today, Dr. Johnson and Dr. Edwards will discuss the connection between gout and kidney health, how uric acid is regulated, and the challenges patients face when both conditions exist. Dr. Edwards, take it from here. Dr. Larry EdwardsThanks, Ian. I'm happy to be joined today by Dr. Richard Johnson, who's a board-certified nephrologist, an internationally recognized researcher, and a member of the board of directors of the Gout Education Society. Welcome to you today, Rick. What I'd like to do is ask you to just briefly here talk about your interest in gout, how that came about, gout and uric acid. Dr. Richard JohnsonYeah. Well, first off, thank you, Larry, for inviting me to be on this podcast. It's a real delight to see you again and to interact with the people who are interested in gout. I'm a kidney doctor, and gout is very common in kidney disease. And so, just by nature, I've seen many patients with gout. But what happened was, in my research, where I was investigating mechanisms of kidney disease and high blood pressure, I became interested in the role of uric acid in kidney disease and blood pressure. Over the years, I have studied this with National Institutes of Health (NIH) funding and other grants to try to understand if uric acid might have a biologic role in diseases, not just gout, but in diseases such as high blood pressure, chronic kidney disease, metabolic syndrome, and so forth. It's a controversial topic, but that's where I've spent much of my research career over the last twenty-plus years. Dr. Larry EdwardsYou've certainly been at the forefront of that area of investigation over that time period. Can I get you to just do a brief overview of the role the kidneys have in regulating uric acid? Dr. Richard JohnsonYes. It's a very important role for the kidney. Uric acid is a breakdown product of purines, which are nitrogen-containing substances that are in our cells, DNA, and other RNA. And just as we have to get rid of waste, when the purines break down, they form uric acid. In many animals, there's an enzyme that degrades uric acid, and so that's the main way you get rid of uric acid, you know, like most mammals do. But humans and some other species, like apes and also birds, and reptiles, lost this enzyme. And so we have to get rid of uric acid from our body a different way. We don't have the enzyme to degrade uric acid, and so we have to get rid of it typically through the urine. And about two-thirds of the uric acid we get rid of goes out through the kidneys into the urine. One-third is removed by the gut. So the gut, or intestines, especially the large intestines, have bacteria that degrade uric acid. There's some movement of uric acid in and out of the intestines, and about one-third of uric acid is removed by the gut. When people start developing kidney disease, they'll start to have some problems with excreting uric acid through the kidneys because with less kidney function, there's less filtering, and it's harder to get the uric acid out. And so the intestines increase their workload to remove uric acid a little bit in response to that. But it's usually not enough, and so uric acid starts to be retained in our blood. As the uric acid levels go up, we become at risk for gout and other complications associated with high uric acid. But when the kidneys are not working, the uric acid levels tend to go up. In people who start dialysis, for example, about half of them will have a uric acid level of greater than seven. It's very, very common to develop gout with kidney disease because you're retaining the uric acid. So, kidney disease is a major cause of gout because as you get worse kidney disease, your uric acid tends to go up, and as the uric acid levels get over seven, the risk increases for the uric acid to crystallize into joints and to cause gout. It's been known for a long time that you can develop gout because of your diet, you know, from eating foods very rich in purines. Beer and alcohol will generate uric acid. Sugar can generate uric acid. So you can raise your uric acid by diet, but the two other major risk factors are genetics, if you have a genetic predisposition to have gout, and the other is if you develop kidney disease, because as you develop kidney disease, you retain uric acid. So, kidney disease is very important in people with gout, and everybody with gout should have their kidney function tested. Dr. Larry EdwardsAnd genetic mutations in these transport systems, both in the gut and in the proximal part of the kidney, I think, are very important and have been researched extensively here for the past fifteen years. I have always been impressed over the last thirty, forty years that I've been looking at these things that uric acid was so tightly regulated by multiple transport systems in the kidney transport systems in the gut that you talked about. Why do you think uric acid has that much influence as far as the body is concerned? Dr. Richard JohnsonWell, you know, there is this problem where if the uric acid levels go up really high, and this is particularly seen in some animals that also lack this enzyme. So we lack this uricase enzyme that, if we had that enzyme, it would protect us if our uric acid levels go up. It would degrade the uric acid, and it wouldn't matter if you had kidney disease or not. But in some animals, especially reptiles and birds, for example, if their kidney function gets worse, they can retain very high levels of uric acid, where the crystals don't just form in the joints, but also in the kidneys and in the heart and throughout the body, and it's actually got the name visceral gout. It's fatal, basically. It's really massive crystallizations associated with aneurysms and severe high blood pressure. Visceral gout is a problem. Now, in humans, we rarely see visceral gout, but there are reports. I was on a paper that described a couple hundred cases of uric crystals forming outside of joints. And usually these are people with kidney disease, and the uric crystals just overwhelm. You can find them in the heart, in the blood vessels, in the kidneys, in the skin, in the eyes. And I've seen a few patients with this over the years, and it's really a horrible syndrome often associated with uric acid levels of fifteen or higher. So the kidneys, though, become so important for getting rid of uric acid. And it's controlled in the tubules. So what happens is after the blood is filtered in the filters of the kidneys, we have millions of filters called glomeruli. And then the urine runs down tubules until it gets into the ureter and then goes into the bladder. It's full of urine, and then you excrete it. But the urine is initially partially filtered. It's first filtered,...

    30 min
  6. Living with Gout: Breaking the Silence on Stigma and Struggle

    10/30/2025

    Living with Gout: Breaking the Silence on Stigma and Struggle

    Welcome to season two of Kicking Gout in the Acid. This season will dive into additional topics of importance to not only those with gout, but for those treating the disease as well. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. This episode of Kicking Gout in the Acid features a conversation between Dr. Larry Edwards and Gary Ho, Executive Director and Co-Founder, Gout Support Group of America. The two explore the connection between gout and mental health, highlighting the emotional toll of the disease, the stigma patients face, and the importance of correcting misconceptions. The episode features a candid conversation with a gout patient and offers insights for both patients and healthcare professionals on improving care and understanding Key Takeaways: The impact of gout goes beyond physical symptoms. Chronic pain, frequent flares and physical limitations also lead to mental anguish, which can be compounded through feeling unheard or dismissed by healthcare providers. The stigma surrounding gout is often tied to outdated beliefs about diet and overindulgence. Many physicians also hold biases. Despite clear evidence that gout is a genetic disease, the stigma surrounding the disease leads to shame and guilt in those with the disease. Misdiagnoses or dismissals of symptoms can occur, so it’s important for patients to monitor their flares and medical professionals to take patient-reported symptoms seriously. Don’t give up—find your voice, seek support, and advocate for your health. There are resources for those dealing with the disease. Find support through the Gout Support Group of America, the Gout Education Society and other organizations. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Crystal Clear Checklist Kicking Gout in the Acid is sponsored by Sobi. Podcast Transcript Ian PonitzHello, and welcome to Kicking Gout In The Acid, a podcast from the Gout Education Society. My name is Ian Ponitz, and I'm your host for this series. Kicking Gout In The Acid features conversations between Dr. Larry Edwards, chairman and CEO of the Gout Education Society, and experts on the disease. Each episode will dive into important topics that you, the listener, should know about gout. The goal? To feel empowered to get gout under control. In this episode, Dr. Edwards is joined again by Gary Ho, co-founder and executive director of the Gout Support Group of America, a partner organization to the Gout Education Society. Today, Gary and Dr. Edwards will discuss the emotional and mental health impact of gout, the stigma surrounding the disease, and how better understanding can lead to better care. Dr. Edwards, take it from here. Dr. Larry EdwardsThanks, Ian. We're very happy today to have Gary Ho, the executive director and co-founder of the Gout Support Group of America, with us. It's been several months since you were last on our Gout Education Society podcast, Gary. Just maybe you could tell us very quickly a little bit about the Gout Support Group and what you've all been up to over the past few months. Gary HoYeah, absolutely. Thank you, Dr. Edwards. Thank you for the invitation back. It's been quite busy the last few months. Looking at 2026 so far, we’re continuing to grow at Gout Support Group America. We're actually closing in on 17,000 members. It's pretty amazing looking back to see what we've been able to do. You know, with some of the things that we are addressing currently, we've noticed that there's been a barrier for some reason. People living with gout, when they experience a flare, they don't think of therapy right off the bat. There's a barrier that stops them from thinking about therapy or even keeping on their medication. And we believe with the Gout Support Group of America, it's the understanding of the gout journey itself. We've actually leaned into that, and so we've been working very hard. We created a GSGA gout roadmap that we will be launching very soon with our rebuilt website. So that will be launching in maybe a couple weeks. We're super excited about it, and it's going to be a tool for the community, for people living with this disease. No matter what chapter you're in in your journey, you can actually turn to this roadmap and identify where you're at, and then it will give you encouragement, direction, and insight into the next step towards quality of life. So a lot of stuff is happening, and of course, you know ACR is right around the corner, so we're preparing for that. Dr. Larry EdwardsYeah. Well, that's excellent, and that sounds like a great approach to gout as a disease, that it's not “take a pill and forget about it.” It needs constant tweaking and following up to make sure that your uric acid, of course, is staying in the right range, and just what options are open to you as things improve or don't improve. So that sounds like it's gonna be terrific. I've been fortunate over the last couple years, Gary, to listen to the story of your involvement with gout. And along with that, there was a lot of misdirection, misinformation, as well as misdiagnosis, that kind of stretched things out for you and caused some undue suffering over time. I think that your story, your ability to overcome those problems, of staying self-aware, of looking for the right answers and not giving up on that, and not just giving in to the disease, makes you a model of what it takes to be a good sufferer of gout as far as being engaged in the treatment part of it. Also, in your history, I know we're not going into full detail of that since we covered that a few months ago, but, you know, there were a number of times where you reported that there was some significant sadness and just frustration with your clinical course. I'd like you to discuss in a little more detail just what that was all about. For instance, just the emotional toll that a disease like gout can take, where there's chronic pain, where there's physical limitations, where there's frequent flares that knock you out of the whole game of life for a while. Can you tell us a little bit about your personal experiences in that regard? Gary HoYes. Thank you for that question. Mine was a 16-year journey of receiving a diagnosis. In fact, getting someone to actually hear what I'd been living through with gout and unmanaged gout. So when we think of gout, we automatically think pain, big toe throbbing, intense, chronic, and all that is true, but beyond the physical pain, many people underestimate the mental anguish that someone goes through. My experience is not unique, unfortunately. It's just not. The fact of the matter is, when someone comes to their physician, someone that they trust and really look up to and hope to get some answers from, and they tell this physician, trusted partner, about their personal experiences, and then to walk away not feeling heard or belittled, that experience is beyond just the physical. It affects your mental well-being. When a person’s living with gout, they're experiencing pain, they're reaching out, but they're not able to feel like they're heard. They're not able to find that answer, solution, or even a direction on what to do next. They think it's their fault. Dr. Larry EdwardsYeah. Gary HoI mean, that takes a huge toll on your well-being. So it's not just physical, it is emotional. And I would say the emotional is just as important as the physical pain that one goes through. Dr. Larry EdwardsYeah, there's been some papers recently written on the stigma of gout, of how people around the gout sufferer view the disease, and how that might cut off communication, which might be very hurtful to the person suffering from gout. For somebody to dismiss it as a few days of pain here or there, when in fact it really is an isolating thing. We did a study and looked at physicians and the bias that they hold for a disease like gout, and it's really disappointing for the profession. It was a small study, but it was clear that physicians come into diagnosing and seeing patients in their clinics with these preconceived notions about why the person has gout to begin with. I think part of the blame game is that there's long been too much emphasis on diet and obesity as a cause of gout. We now know that it's a genetic disease. It's something that you inherited, that obesity may have an amplifying effect a bit on that, but at its core, it's a genetic disease. People have images from movies or history, everybody knows a little bit about King Henry VIII and his fight with gout, and have this feeling that it's a disease of overindulgence, which is clearly not the case. In the past 20 years, those myths have all been laid to rest. But the bias, the bigotry, the stigma still persists. I think that that makes life hard for patients with gout. You and GSGA have talked to a lot of people, 17,000 now, is that right? Gary HoWe're heading there, yes. Dr. Larry EdwardsGood heavens. You get a lot of input on these kinds of questions from your constituents in the GSGA. Gary HoMm-hmm. Dr. Larry EdwardsDo you have stories of how people’s daily lives are affected? I know it was dramatic for you. Do you have people that suffer these biases or have really significant limitations? Gary HoYeah, we do. You know, stigma within the gout community is real. When it comes to stigma, we as a community suffer a lot. Even today, when you ask people about gout,...

    18 min
  7. 05/30/2025

    The Gout Treatment Journey: Insights from a patient

    Gout, the most common form of inflammatory arthritis, can wreak havoc on the body. The good news? It’s easily managed with the right help. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. For the last episode of this season of Kicking Gout in the Acid, Dr. Larry Edwards is joined by Gary Ho, a gout sufferer turned advocate. Gary has lived with gout for more than 30 years, taking his experience with the disease and forming the Gout Support Group of America, a partner organization to the Gout Education Society under the Alliance for Gout Awareness group. The two discuss Gary’s experience living with gout, how to be an advocate for yourself, and what living with the disease under control looks like. Key Takeaways: Living with gout carries frustrating stigmas and myths alongside pain in the joints; many with gout see the disease as embarrassing and self-inflicted. In reality, the disease is underpinned by genetics and is the most common form of inflammatory arthritis. It’s important to find your voice: If you don’t think you’re getting the level of care needed for your gout, find a second opinion. Those with gout need proactive care, that is, receiving care that reduces uric acid levels in the body. Gout doesn’t have to stop you from living your life. Maintaining one’s uric acid levels to less than 6.0 mg/dL allows those with the disease to enjoy their favorite foods and beverages in moderation. If you have gout, you don’t need to suffer alone. Find support through the Gout Support Group of America, the Gout Education Society and other organizations. Start your journey with gout treatment today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Kicking Gout in the Acid is sponsored by Sobi.

    32 min
  8. 05/27/2025

    Managing Gout Alongside Related Health Conditions

    Gout, the most common form of inflammatory arthritis, can wreak havoc on the body. The good news? It’s easily managed with the right help. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. In this episode of Kicking Gout in the Acid, Dr. Larry Edwards is joined by Gout Education Society International Advisory Council member Dr. Puja Khanna, rheumatologist at the University of Michigan. The two discuss the variety of health conditions, also known as comorbidities, commonly seen alongside gout and how they can impact those with the disease. Key Takeaways: Gout is often associated with other metabolic diseases like obesity, kidney disease, heart disease, diabetes, and hyperlipidemia – it’s not simply pain in the toe. Gout comorbidities impact the treatment of gout; for example, NSAIDs are not a good option for anti-inflammatory treatment of flares in those with kidney disease or diabetes, prompting the use of different options. Those with gout should be on the lookout for symptoms of comorbidities and talk with their doctor to find the best treatment plan for themselves. Education is a crucial part of gout management; when combined with self-advocacy, those with gout can reduce the disease’s burden on the body and avoid the negative complications of comorbidities. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Kicking Gout in the Acid is sponsored by Sobi. Podcast Transcript Ian PonitzHello, and welcome to Kicking Gout In The Acid, a podcast from the Gout Education Society. My name is Ian Ponitz, and I'm your host for this series. Kicking Gout In The Acid features conversations between Dr. Larry Edwards, chairman and CEO of the Gout Education Society, and experts on the disease. Each episode will dive into important topics that you, the listener, should know about gout. The goal? To feel empowered to get gout under control. In this episode, Dr. Edwards will be joined by Dr. Puja Khanna from the University of Michigan. The two will discuss the role of comorbidities, or related health conditions, alongside gout, how they impact the treatment of gout, and what those with gout can do to mitigate their risk. Dr. Edwards, take it from here. Dr. Larry EdwardsThanks, Ian. I'm joined today by Dr. Puja Khanna from the University of Michigan. She is an expert in gout, gout treatment, and is also a member of our advisory council on the Gout Education Society. Puja, maybe you'd like to fill in people a little bit more about your affinity for gout? Dr. Puja KhannaThank you so much, Dr. Edwards. For all purposes, I am a rheumatologist, but my area of expertise has been gout for close to 15, 16 years. I am a trained epidemiologist as well, so my focus has been patient-oriented outcomes. And gout seemed to be a space in rheumatology that had some work going on, but not as much as rheumatoid arthritis, versus more of the orphan diseases, which were scleroderma and lupus. And that's where I focused in on gout, which was a very common disease known to man for more than 400 years, but we still had very limited treatments, and that's what prompted me to enter the arena of clinical trials. I've had the fortune of participating as principal investigator in a bunch of trials, including in acute gout and urate-lowering therapies for chronic gout. But where my passion lies is honestly with my patients, and I think there's a lot of stigma attached to gout, where we need more and more focus and patient advocacy. So, that's where we are right now in my career trajectory. For the University of Michigan, my role is to serve as the associate chair of clinical affairs, while I also dabble a little bit in my research area, which is gout. Dr. Larry EdwardsGood. Terrific. We'll be working right along those lines of individual care for gout patients because we're gonna be talking today about the comorbid conditions, the metabolic diseases that are pretty common that occur alongside gout, and talk a little bit about what that interconnection is, and what we think the cause of that relationship is, maybe. Do you have some thoughts on that? Dr. Puja KhannaAbsolutely. As we all know, gout is common, but what we have seen is that attention to gout comes forward only when the patient has an acute flare-up in their joints. I think that's where the travesty lies, because gout happens because of high levels of uric acid, which we define as hyperuricemia. Hyperuricemia is not just in the joints, as we know. It's actually a systemic disease. Uric acid can deposit itself across the body, and that is precisely the reason why we see that association of gout with obesity, or gout with kidney disease, gout with heart disease, and gout with diabetes. So, I think that's where the focus should move, honestly, in my opinion, that we start to think only of the joint and we only treat gout when joints get involved. But we need to take a step back and think about all of the comorbidities that start earlier than gout, and perhaps we want to bring the focus in on the urate piece and start treating a priori, meaning preemptively, so that we can address the urate burden before it becomes a systemic disease. And there is very little, at that point, that we can reverse, because other organ systems have been involved, and you have developed more comorbidities, and as a result, treatments are difficult. Dr. Larry EdwardsYeah. You mentioned a number of the metabolic diseases that gout's associated with, including obesity, heart disease, and diabetes. I guess hypertension's probably the most common of those. And taken altogether, along with kidney disease and elevated lipids, I guess all of those taken together is what the medical profession calls metabolic syndrome, which used to be Syndrome X. I always loved that because it has this mysterious ring to it. But metabolic syndrome is very closely associated with, as you say, hyperuricemia and gout. Are there mechanisms that we can think of that would be true of? You'd said the inflammation outside of the joints, so that there's more systemic inflammation, maybe. You think that's a cause? Dr. Puja KhannaThat is absolutely the cause, because if you want an analogy, it's similar to elevated blood sugars or high lipid levels. When you have high levels of uric acid circulating in the body, that creates what we call a chronic level of inflammation in the body. Now, depending on where the uric acid will go and deposit itself, and as we grow older, there is the factor of what we call senescence. As we grow older, every organ system responds differently to the inflammation that is already in the organ system, and then you add another load. So, we've noticed in our epidemiologic studies that as we grow older, we have more acute flare-ups. And as a result, the frequency will grow, and you will require things such as steroids for management, or one medication is better in managing the disease, versus the other is more effective, and it becomes harder and harder to treat. I think there is definitely that element where there is a direct correlation. However, we struggle to show this causal relationship in large observational studies. That is where we want to show proof. And with the various studies that are going on right now, we are slowly and steadily making headway. Dr. Larry EdwardsYeah. So I think that the message is that control of gout is both related to control of these other metabolic diseases, and control of the other metabolic diseases is somehow very closely aligned to how easy it would be to get gout under control. I think for all those people with heart disease and diabetes and hypertension, ignoring their gout is really anti-productive because they're gonna have a much harder time controlling those conditions. Now, let's talk for a little bit about how having these various metabolic conditions, like kidney disease and heart disease and diabetes, affects the kind of medications that we use to treat both the inflammation of gout and the cause of gout, the hyperuricemia. Can you comment on those? Dr. Puja KhannaAbsolutely. One of the challenges that we have is that with the urate burden, the uric acid in our body is cleared through our kidneys primarily. So, 75% of it is cleared through the kidneys, whereas 25% is going to be cleared through the gut. And what happens is that if you have kidney disease, maybe because you have hypertension or you have diabetes, or you have heart disease, your kidneys are not functioning well, and the clearance of urate also goes down. That is one of the key things that lowers your ability to process, for the body to process that acute flare-up as well. And that is important to remember because folks who have kidney disease end up veering away from medications such as non-steroidal anti-inflammatories or even medications like Colchicine because we have realized that they can actually cause more adverse effects, for instance, not only on the kidneys, but also on the gut. So you rely on a class of medications, which is called corticosteroids. Now, the beauty of corticosteroids is that they are very effective, but they're only effective when you start them promptly as soon as an acute flare starts. There is a large body of data to show similar efficacy with Colchicine and non-steroidals. But the challenge with corticosteroids is what? That they also have their own side effects. For instance, in a patient who is diabetic,...

    23 min
  9. 05/20/2025

    The Socioeconomic Impact of Gout and Barriers to Treatment

    Gout, the most common form of inflammatory arthritis, can wreak havoc on the body. The good news? It’s easily managed with the right help. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. In this episode of Kicking Gout in the Acid, Dr. Larry Edwards is joined by Gout Education Society International Advisory Council member Dr. Jasvinder Singh, rheumatologist at Baylor College of Medicine. The two discuss the socioeconomic impact of gout and barriers to proper treatment to showcase how the disease affects more than just the body. Key Takeaways: Gout comes with a variety of indirect costs (work absenteeism and loss of productivity) and direct costs (doctor visits, medications, and lab tests) that are often unseen by those with the disease. Early and ongoing management of the disease is vital to reducing the economic burden on patients. A lack of rheumatologists in the United States puts additional pressure on primary care physicians to manage the disease early; however, delayed referrals to rheumatologists can negatively impact patient outcomes. While new, there is potential for new therapies and management strategies. The current priority for gout management lies in addressing adherence issues for patients and knowledge gaps for medical professionals. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Kicking Gout in the Acid is sponsored by Sobi. Podcast Transcript Ian PonitzHello, and welcome to Kicking Gout In The Acid, a podcast from the Gout Education Society. My name is Ian Ponitz, and I'm your host for this series. Kicking Gout In The Acid features conversations between Dr. Larry Edwards, chairman and CEO of the Gout Education Society, and experts on the disease. Each episode will dive into important topics that you, the listener, should know about gout. The goal? To feel empowered to get gout under control. In this episode, Dr. Edwards will be joined by Dr. Jasvinder Singh, rheumatologist from Baylor College of Medicine, to look at the socioeconomic impact of gout, barriers to treatment, and the importance of educating both those with the disease and those involved with its treatment. Dr. Edwards, take it from here.Dr. Larry EdwardsThanks, Ian. Now, I'm joined today by Gout Education Society international advisory council member Dr. Jasvinder Singh. Jas, would you be able to tell the listeners just what your interest in gout has been over the years and what your current role is with Baylor University in Houston?Dr. Jasvinder SinghThanks, Larry, for the invitation, and thanks to the Gout Education Society for having this conversation. I am a rheumatologist here at Baylor College of Medicine and a staff physician at the Michael E. DeBakey VA Medical Center. I've been interested in gout as a condition since the beginning of my career as a rheumatologist. I got drawn to this disease after my fellowship completion as a staff physician at the Minneapolis VA Medical Center, where the majority of our inpatient consults tended to be either sick people with vasculitis and lupus or people with gout flares and concomitant septic arthritis in gout or a question of gout or management of gout. So, I clearly sensed that there was a big need for understanding this disease and controlling it better, and I got drawn into research as I saw other people in the field who were very passionate about this research, including Ralph Schumacher, Michael Decker, and obviously you as well, Larry, through my connections to all three of you through the Omri. So, I still feel like there's a lot to be done in this field, and I continue to enjoy working in this disease, disease mechanisms, and treatment, and still find it very exciting and an important area to continue to work in, both as a clinician and as a researcher. Dr. Larry EdwardsThanks, Jas. We're delighted to have you with us today. In our previous three podcasts that we've done for the Gout Education Society, we focused on how gout affects a person's health and happiness. For this episode, I'd like us to focus instead on how gout may affect a person's wallet, and in that regard, look at the costs of gout, the direct costs as far as doctor's visits, laboratory testing, hospital visits, medications, and the indirect costs as far as being absent from work. Then, I think we could discuss a little bit on whether or not early management, treatment, and recognition of gout could reduce some of these economic burdens for patients who have gout. Can you tell us a little bit about these direct costs and indirect costs? Dr. Jasvinder SinghYeah. So Larry, I think that is really a very important aspect of gout management. The direct cost obviously hits the patient right in the pocket and makes it challenging for patients to take good care of the condition. And there are humongous amounts of indirect costs in gout, primarily because it's not recognized as a serious disease or a chronic disease. And many times, patients and sometimes even providers in the initial few years of gout think of it as separate acute attacks by years and not requiring treatment. And that's what leads to a significant impact on work productivity, days of work lost. People might have challenges keeping their jobs because of recurrent attacks and not being able to show up at work. It has impacts on their social lives in addition to having direct effects on productivity, and that's what leads to a lot of indirect costs of gout. The reason we have humongous amount of indirect costs from gout is related to not only the fact that gout is the most common inflammatory arthritis in adults, but also that it may not get the same respect and attention that something similar to it, like rheumatoid arthritis, gets in terms of the need to treat the target and manage it and keep it under control. Keeping gout under control obviously will lead to fewer flares and less effect on quality of life, less pain, better function, but also better productivity and fewer days of work loss in absenteeism and decreased presenteeism, both at work and for people at home who are running and taking care of their families. We are also aware of a lot of research that has already shown us that people who have gout with frequent flares tend to accumulate both a higher direct cost out of pocket, as well as higher indirect costs due to all of these downstream effects. Better management, potentially, to treat the target, an approach where you have a goal for the patient to get their disease treated and kept under control, has the potential to decrease not only the humongous indirect cost, but also the direct cost of this. Some of this comes from expensive urgent care, emergency room, inpatient visits, and hospitalizations, a majority of which can be avoided and lead to not only cost savings, but also better outcomes for the patient and less resource utilization overall. Dr. Larry EdwardsSure. A lot of this stems from what you mentioned earlier, that the disease itself. Gout, although it's excruciatingly painful and a major disease to those that have it, a lot of times healthcare providers view it as not as important as the other comorbid conditions like blood pressure, kidney disease, and heart disease that these patients may also have. I think getting focused early on and making it imperative that, not only do we have a firm diagnosis that what the patient's complaining about is gout, but also that they have a care provider that understands the importance of treating this, not just to eliminate the flares, but also to help control the other comorbid problems like the diabetes and blood pressure as well. Yeah, I think that's the case. If we could treat everybody early, then this would be a rather inexpensive disease to have cured, but it's unfortunately not that way. Let's turn from those costs and talk about the barriers to treatment access and the role this plays in the overall socioeconomic impact of gout. We know that the overwhelming percentage of gout patients are initially seen and cared for by primary care physicians, like GPs, family medicine internists, and ER physicians, especially in the early stages of gout. Patients who have more advanced disease or those who don't respond well to initial therapies for the gout are frequently referred to arthritis specialists or rheumatologists. How are the economics of gout affected by this referral pattern? Dr. Jasvinder SinghI think that, as you correctly stated, the majority of gout is cared for by primary care physicians and only those that they think are not optimally controlled are referred to rheumatologists. But this does reflect the harsh reality, which is that there's a lack of a big army of rheumatologists available in the United States, at least. There's a shortage of rheumatologists, and, therefore, access to rheumatology care is somewhat limited in many parts of the country. Even in parts of the country where you have a lot of rheumatologists, such as in big cities, they have long wait times. Primary care providers frequently refer all of their rheumatoid arthritis patients and lupus patients to rheumatologists, but not every gout patient. I think one of the other issues that surprises you and me a lot is that we don't have lots of folks focused on gout. A lot of rheumatologists are focused on gout. Obviously, this is something that is a passion for you, me, and several of us, that a lot of rheumatologists sometimes may be interested in autoimmune di

    25 min
  10. 02/18/2025

    Navigating Myths, Misconceptions and Stigma to Improve Management

    Gout, the most common form of inflammatory arthritis, can wreak havoc on the body. The good news? It’s easily managed with the right help. Whether you’ve been recently diagnosed, care for someone suffering, or are a medical professional treating the disease, the Kicking Gout in the Acid podcast can help you learn more. In this episode of Kicking Gout in the Acid, Dr. Larry Edwards is joined by Gout Education Society Board of Directors member Dr. Paul Doghramji, certified family practice physician at Collegeville Family Practice and physician advisor at Pottstown Memorial Medical Center in Pennsylvania. The two discuss the many misconceptions and myths about gout related to such topics as its prevalence, cause, treatment strategies and the role of diet and lifestyle modifications. Key Takeaways: Gout is more common than it’s often perceived – more than 12 million Americans are estimated to have the disease. Gout myths are pervasive. Many people incorrectly believe gout is self-inflicted; in truth, gout is largely hereditary and not commonly brought on by poor diet and lifestyle choices. Home remedies such as cherry juice are commonly seen as easy treatments for the disease; however, effective management includes anti-inflammatory medications and uric acid-lowering drugs. Continual educational opportunities for both patients and medical professionals alike are key to breaking the many myths, misconceptions and stigma surrounding gout. Start your journey with gout today via the Gout Education Society website and sign up for the monthly newsletter. Follow the Gout Education Society on X and Facebook Looking for nearby gout specialists? Find rheumatologists, nephrologists and more via the Gout Specialists Network. Educational Materials: Gout Patient Brochure Medical Professional Guide Kicking Gout in the Acid is sponsored by Sobi. Podcast Transcript Ian PonitzHello, and welcome to Kicking Gout In The Acid, a podcast from the Gout Education Society. My name is Ian Ponitz, and I'm your host for this series. Kicking Gout In The Acid features conversations between Dr. Larry Edwards, chairman and CEO of the Gout Education Society, and experts on the disease.  Each episode will dive into important topics that you, the listener, should know about gout. The goal? To feel empowered to get gout under control.  In this episode, Dr. Edwards will be joined by Dr. Paul Doghramji, certified family practice physician at Collegeville Family Practice and physician advisor at Pottstown Memorial Medical Center in Pennsylvania. The two will discuss common myths, misconceptions, and the stigma surrounding gout. We'll spend today's episode breaking down these notions in the hopes of improving education surrounding the disease. Dr. Edwards, take it from here.  Dr. Larry EdwardsThanks, Ian. We're joined today by one of the board members of the Gout Education Society, Dr. Paul Doghramji. Paul is a primary care physician in the Philadelphia area and has had a keen interest in gout for a while. Paul, let me have you introduce yourself.  Dr. Paul DoghramjiYes. Thank you, Larry. It's great to be here. Paul Doghramji. I am a family physician, board-certified in family practice, and I've been that way for a good many years. I got involved in the area of gout, oddly enough, in somewhat of a curved way. About 20-some years ago, my main area of interest was sleep disorders, and one of the things that I wrote about was restless leg syndrome. And then we did this huge national expose on the biology of leg disorders, so I wrote about restless leg syndrome, but at the same time, I also wrote about other things that can happen to legs, like gout.  So, I started writing about gout, and it opened a whole world of things that I got to know about when it came to gout and hyperuricemia. So, I did a lot of writing, and then after that, I still did a lot of education for my primary care providers, as well as the lay public on hyperuricemia and gout. And it's been wonderful to get all this information that I can share with primary care providers, be they MDs, DOs, nurse practitioners, physician assistants who do primary care, but also laypeople, about, again, the interesting things they need to know about gout, and also, as well, some of the misconceptions. So, it's been a really good journey, and I'm very pleased to be here to talk more about it.  Dr. Larry EdwardsWell, we're glad you're here, too, Paul. I'm glad that you picked up on gout as an area of interest. After all, family practitioners, primary care doctors, and deliverers are the people who see most of the gout. We're gonna start off today, really talking about myths and misconceptions.  Gout's a disease that's been around literally forever. There are inscriptions in the pyramids about gout. There was lots written in the ancient Greek and Roman medical literature about gout. And it's not surprising that a disease with that kind of history has picked up a lot of misconceptions and myths along the way. Unfortunately, a number of those can really change the way people look at gout as a disease, look at patients that have gout as potentially people who brought this disease on themselves.  I think it's an important part of education not just to talk about what really causes gout and all, but to dispel some of these misconceptions. What we're gonna do today is just run through some of the more common ones that we hear about all the time to get your take on them.  One is that gout is a relatively uncommon disease of minor consequence compared to the other kinda higher-priority diseases that follow gout around, such as high blood pressure and diabetes, kidney disease, heart disease. And so, the physicians might not have the time to address gout just because they're worried about these other things that are the close relatives of gout. What do you think about that, Paul?  Dr. Paul DoghramjiWell, first of all, interestingly, the last patient that I saw right before this recording was a gentleman who came in with knee pain, with a diffusion that most likely is from gout. I see gout quite often, and a lot of primary care providers do see it. I think the problem is that they don't actually identify it as being gout because gout eventually goes away. Like, within a couple of weeks, it goes away. And they attribute it to maybe a strain, a sprain, overuse, that sort of stuff.  So, it's a lot more than what you think, and a lot of gout actually goes unrecognized and undiagnosed. In regular practice, because we see men and women in their middle age and in their later years, especially those who have hereditary problems with gout, there's a lot of it there. You just have to have a high index of suspicion with patients presenting with acute joint pain, whether it's traumatic or not, that occurs predominantly in the peripheral joints, like the feet, the toes, the fingers, and the wrists, and occurs in a generally monoarticular way. So, it's a lot more than what we think it is.  Dr. Larry EdwardsYeah. Absolutely. And it is actually one of the most common forms of arthritis. We see a lot of advertisements on TV about psoriatic arthritis and rheumatoid arthritis, and various other things, but gout is much more common. In fact, it's as common as a lot of those other medical conditions you talked about, almost as common as diabetes. So, it's out there. This idea that it's just a minor concern, how would you address that?  Dr. Paul DoghramjiWell, it's not a minor concern. The first thing I think we should know is that statistics show that about 20% of adults have hyperuricemia, high uric acid levels. That's a lot of people. Only about maybe 10%, 20% of those people might get a gout attack, so we don't really understand in some ways the, you know, why some people get it and why some people don't. But it's a lot out there, and hyperuricemia is a bad thing. In many ways, we should think about it as too much blood pressure, too much sugar, too much cholesterol, where not only can it affect your joints, but it can also affect other areas.  You know, Larry, we're understanding that high uric acid can also be a risk factor for cardiovascular disease and renal disease. So, uric acid, in high amounts, can crystallize and cause damage and inflammation in many other organs of the body, not just joints.  Dr. Larry EdwardsAbsolutely. It's certainly not a minor condition, and it should be up at the top of the list of concerns, I think, when physicians see patients.  Dr. Paul DoghramjiAs far as the joint parts are concerned, in a lot of people who get gout attacks maybe once or twice a year or so, there's this misconception, if I just treat the gout attack, that's enough, because the rest of the time, they're fine. And what a lot of people don't understand is that in between these episodes, in these intercritical periods, uric acid is still damaging the joints, and as the months and years go by, it can increase the probability of developing degeneration of those joints and causing premature osteoarthritis.  So, not only is it damaging joints when they have a gout attack, but also in the intercritical periods, there are things going on. So, it's necessary not only to treat the gout attack, but also to do something about the uric acid so it doesn't damage the joints and possibly other parts of the body.  Dr. Larry EdwardsI think that's a good segue to one of our other common misconceptions about the disease, and that is that people think that when their joint is swollen and painful that they have gout, and when it's calmed down and there aren't any symptoms in the joint, they no longer have gout, not appreciating that this is a chronic disease that you will always have with you if you've had a gout flare in the past.  I think that leads to other problems, and I want to know if you see this: that patien

    32 min

Ratings & Reviews

5
out of 5
3 Ratings

About

Learn more about gout causes, symptoms, and treatment with Gout Education Society Chairman, Larry Edwards, MD, MACR, MACP, alongside other gout experts from across the world.

You Might Also Like